Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy

Radiat Oncol. 2015 Jul 10:10:141. doi: 10.1186/s13014-015-0436-2.

Abstract

Background: Adjuvant radiotherapy (RT) for left-sided breast cancer increases cardiac morbidity and mortality. For the heart, no safe radiation threshold has been established. Troponin T is a sensitive marker of myocardial damage. Our aim was to evaluate the effect of left-sided breast cancer RT on serum high sensitivity troponin T (hscTnT) levels and its association with cardiac radiation doses and echocardiographic parameters.

Methods: A total of 58 patients with an early stage, left-sided breast cancer or ductal carcinoma in situ (DCIS) who received adjuvant breast RT without prior chemotherapy were included in this prospective, non-randomized study. Serum samples were taken before, during and after RT. An increase of hscTnT >30 % was predefined as significant. A comprehensive 2D echocardiograph and electrocardiogram (ECG) were performed before and after RT. Dose-volume histograms (DVHs) were generated for different cardiac structures.

Results: The hscTnT increased during RT from baseline in 12/58 patients (21 %). Patients with increased hscTnT values (group A, N = 12) had significantly higher radiation doses for the whole heart (p = 0.02) and left ventricle (p = 0.03) than patients without hscTnT increase (group B, N = 46). For the left anterior descending artery (LAD), differences between groups A and B were found in volumes receiving 15 Gy (p = 0.03) and 20 Gy (p = 0.03) Furthermore, after RT, the interventricular septum thickened (p = 0.01), and the deceleration time was prolonged (p = 0.008) more in group A than in group B.

Conclusions: The increase in hscTnT level during adjuvant RT was positively associated with the cardiac radiation doses for the whole heart and LV in chemotherapy-naive breast cancer patients. Whether these acute subclinical changes increase the risk of excessive long-term cardiovascular morbidity or mortality, will be addressed in the follow-up of our patients.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers
  • Breast Neoplasms / radiotherapy*
  • Carcinoma, Ductal, Breast / radiotherapy*
  • Carcinoma, Intraductal, Noninfiltrating / radiotherapy*
  • Echocardiography, Doppler
  • Electrocardiography
  • Female
  • Heart / radiation effects*
  • Humans
  • Mastectomy
  • Mastectomy, Segmental
  • Middle Aged
  • Natriuretic Peptide, Brain / blood
  • Organs at Risk
  • Prospective Studies
  • Radiation Injuries / blood*
  • Radiation Injuries / diagnostic imaging
  • Radiation Injuries / etiology
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted
  • Radiotherapy, Adjuvant / adverse effects*
  • Radiotherapy, Conformal / adverse effects*
  • Radiotherapy, Image-Guided
  • Sensitivity and Specificity
  • Troponin T / blood*

Substances

  • Biomarkers
  • Troponin T
  • Natriuretic Peptide, Brain